Rx/reimbursement adult incontinence sales slowed down a bit in light of the pandemic in both retail volume and current value terms in 2020. Majority of the attention was focused on the away-from home channel which slightly affected sales.
Heavy and moderate options remained dominant in Rx/reimbursement adult incontinence in 2020. This trend is similar to the one seen in retail, as consumers continued to hold lower trust in light options.
Rx/reimbursement adult incontinence sales are set to come back to a regular growth pace once the pandemic is over. 2021 will be the first year of normalisation, with retail volume and current value growth set to pick up afterwards and through the rest of the forecast period.
No major shifts in the sales structure of Rx/reimbursement adult incontinence are expected over the forecast period. Heavy and moderate adult incontinence is set to remain in the highest demand.
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
Understand the latest market trends and future growth opportunities for the Rx/Reimbursement adult incontinence industry in Kazakhstan with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Rx/Reimbursement adult incontinence industry in Kazakhstan, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
This report originates from Passport, our Rx/Reimbursement adult incontinence research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Home Page